Objectives: To identify a pediatric ventilator-associated condition definition for use in neonates and children by exploring whether potential ventilator-associated condition definitions identify patients with worse outcomes. Design: Retrospective cohort study and a matched cohort analysis. Setting: Pediatric, cardiac, and neonatal ICUs in five U.S. hospitals. Patients: Children 18 years old or younger ventilated for at least 1 day. Interventions: None. Measurements and Main Results: We evaluated the evidence of worsening oxygenation via a range of thresholds for increases in daily minimum fraction of inspired oxygen (by 0.20, 0.25, and 0.30) and daily minimum mean airway pressure (by 4, 5, 6, and 7 cm H2O). We required worsening oxygenation be sustained for at least 2 days after at least 2 days of stability. We matched patients with a ventilator-associated condition to those without and used Cox proportional hazard models with frailties to examine associations with hospital mortality, hospital and ICU length of stay, and duration of ventilation. The cohort included 8,862 children with 10,209 hospitalizations and 77,751 ventilator days. For the fraction of inspired oxygen 0.25/mean airway pressure 4 definition (i.e., increase in minimum daily fraction of inspired oxygen by 0.25 or mean airway pressure by 4), rates ranged from 2.9 to 3.2 per 1,000 ventilator days depending on ICU type; the fraction of inspired oxygen 0.30/mean airway pressure 7 definition yielded ventilator-associated condition rates of 1.1–1.3 per 1,000 ventilator days. All definitions were significantly associated with greater risk of hospital death, with hazard ratios ranging from 1.6 (95% CI, 0.7–3.4) to 6.8 (2.9–16.0), depending on thresholds and ICU type. Each definition was associated with prolonged hospitalization, time in ICU, and duration of ventilation, among survivors. The advisory board of the study proposed using the fraction of inspired oxygen 0.25/mean airway pressure 4 thresholds to identify pediatric ventilator-associated conditions in ICUs. Conclusions: Pediatric patients with ventilator-associated conditions are at substantially higher risk for mortality and morbidity across ICUs, regardless of thresholds used. Next steps include identification of risk factors, etiologies, and preventative measures for pediatric ventilator-associated conditions.
from #Medicine via ola Kala on Inoreader http://ift.tt/1QsOYiN
via IFTTT
Αρχειοθήκη ιστολογίου
-
►
2023
(138)
- ► Φεβρουαρίου (74)
- ► Ιανουαρίου (64)
-
►
2022
(849)
- ► Δεκεμβρίου (61)
- ► Σεπτεμβρίου (74)
- ► Φεβρουαρίου (65)
-
►
2021
(2936)
- ► Δεκεμβρίου (59)
- ► Σεπτεμβρίου (180)
- ► Φεβρουαρίου (325)
-
►
2020
(1624)
- ► Δεκεμβρίου (293)
- ► Σεπτεμβρίου (234)
- ► Φεβρουαρίου (28)
-
►
2019
(13362)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (5586)
- ► Ιανουαρίου (5696)
-
►
2018
(66471)
- ► Δεκεμβρίου (5242)
- ► Σεπτεμβρίου (5478)
- ► Φεβρουαρίου (4835)
- ► Ιανουαρίου (5592)
-
►
2017
(44259)
- ► Δεκεμβρίου (5110)
- ► Σεπτεμβρίου (5105)
-
►
2016
(7467)
- ► Δεκεμβρίου (514)
- ► Σεπτεμβρίου (1038)
- ► Φεβρουαρίου (793)
-
▼
2015
(2119)
-
▼
Δεκεμβρίου
(940)
-
▼
Δεκ 16
(50)
- Separation of proteins by cation-exchange sequenti...
- PAL SPME Arrow—evaluation of a novel solid-phase m...
- Optimization and comparison of miniaturized extrac...
- Development of CT-guided biopsy sampling for time-...
- Comprehensive analysis of serum metabolites in ges...
- Detection of volatile organic compounds (VOCs) fro...
- Longitudinal monitoring of endogenous steroids in ...
- Surface-enhanced Raman spectroscopy in 3D electros...
- Comparative study of the oxidation behavior of sul...
- Emerging flow injection mass spectrometry methods ...
- SpinCouple: Development of a Web Tool for Analyzin...
- Fentanyl Pharmacokinetics in Critically Ill Patien...
- Equity of Access to Critical Care Among Elderly Pa...
- The authors reply
- Ventilator-Associated Events in Neonates and Child...
- Hyperbaric Oxygen Therapy Alleviates Carbon Monoxi...
- A Selective V1A Receptor Agonist, Selepressin, Is ...
- Excellence in Critical Care Units
- Open Lung Approach for the Acute Respiratory Distr...
- Shining a Light on the Problem of Circadian Phase ...
- Neutrophil Toll-Like Receptor 9 Expression and the...
- The authors reply
- Delayed Rapid Response Team Activation Is Associat...
- The authors reply
- Population Pharmacokinetics of Fentanyl in the Cri...
- Should We Embrace the “Open Lung” Approach?*
- The Association Between Low Admission Peak Plasma ...
- Lung Protective Ventilator Strategies: Beyond Scal...
- Organ System Network Disruption in Nonsurvivors of...
- Online Editorial Board Acknowledgment
- Volume Delivered During Recruitment Maneuver Predi...
- Suppressor of sable [Su(s)] and Wdr82 down-regulat...
- Watson-Crick-like pairs in CCUG repeats: evidence ...
- High-throughput sequencing of human plasma RNA by ...
- An active site rearrangement within the Tetrahymen...
- Corrigendum: Transitivity in Arabidopsis can be pr...
- Peptide release promoted by methylated RF2 and Arf...
- Long-range RNA pairings contribute to mutually exc...
- Cytoplasmic poly(A) binding protein-1 binds to gen...
- Applied Sciences, Vol. 5, Pages 1803-1836: Sequent...
- Applied Sciences, Vol. 5, Pages 1869-1881: Kinetic...
- Marine Drugs, Vol. 13, Pages 7419-7432: Structure-...
- Applied Sciences, Vol. 5, Pages 1846-1868: Numeric...
- Molecules, Vol. 20, Pages 22534-22545: A Nanostruc...
- Energies, Vol. 8, Pages 14182-14196: Waste-to-Ener...
- Applied Sciences, Vol. 5, Pages 1837-1845: High Po...
- Energies, Vol. 8, Pages 14197-14218: Designing an ...
- Catalysts, Vol. 5, Pages 2161-2222: Zeolite Membra...
- IJMS, Vol. 16, Pages 29948-29970: Transcriptome Ch...
- IJMS, Vol. 16, Pages 29980-29995: Dietary Compound...
-
▼
Δεκ 16
(50)
-
▼
Δεκεμβρίου
(940)
Αναζήτηση αυτού του ιστολογίου
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Αλέξανδρος Γ. Σφακιανάκης Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,0030693260717...
-
heory of COVID-19 pathogenesis Publication date: November 2020Source: Medical Hypotheses, Volume 144Author(s): Yuichiro J. Suzuki ScienceD...
-
Alimentary Pharmacology &Therapeutics, EarlyView. https://ift.tt/2qECBIJ
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.